MOLINA HEALTHCARE, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that MOLINA HEALTHCARE, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $45.43B | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $40.65B | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | $34.07B | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | $31.97B | Feb 11, 2025 |
| FY2023 | Dec 31, 2021 | $27.77B | Feb 13, 2024 |
| FY2022 | Dec 31, 2020 | $19.42B | Feb 13, 2023 |
| FY2019 | Dec 31, 2019 | $4.27B | Feb 14, 2020 |
| FY2019 | Sep 30, 2019 | $4.24B | Feb 14, 2020 |
| FY2019 | Jun 30, 2019 | $4.19B | Feb 14, 2020 |
| FY2019 | Mar 31, 2019 | $4.12B | Feb 14, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $2.48B | Feb 16, 2021 |
| FY2019 | Dec 31, 2019 | $578.00M | Feb 14, 2020 |
| FY2019 | Sep 30, 2019 | $561.00M | Feb 14, 2020 |
| FY2019 | Jun 30, 2019 | $583.00M | Feb 14, 2020 |
| FY2019 | Mar 31, 2019 | $581.00M | Feb 14, 2020 |
| FY2019 | Dec 31, 2018 | $664.00M | Feb 14, 2020 |
| FY2019 | Sep 30, 2018 | $566.00M | Feb 14, 2020 |
| FY2019 | Jun 30, 2018 | $673.00M | Feb 14, 2020 |
| FY2019 | Mar 31, 2018 | $615.00M | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | $446.00M | Feb 19, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $472.00M | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $1.18B | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | $1.09B | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | $792.00M | Feb 11, 2025 |
| FY2023 | Dec 31, 2021 | $659.00M | Feb 13, 2024 |
| FY2022 | Dec 31, 2020 | $673.00M | Feb 13, 2023 |
| FY2019 | Dec 31, 2019 | $168.00M | Feb 14, 2020 |
| FY2019 | Sep 30, 2019 | $175.00M | Feb 14, 2020 |
| FY2019 | Jun 30, 2019 | $196.00M | Feb 14, 2020 |
| FY2019 | Mar 31, 2019 | $198.00M | Feb 14, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $781.00M | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $1.71B | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | $1.57B | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | $1.17B | Feb 11, 2025 |
| FY2023 | Dec 31, 2021 | $1.02B | Feb 13, 2024 |
| FY2022 | Dec 31, 2020 | $1.08B | Feb 13, 2023 |
| FY2021 | Dec 31, 2019 | $1.04B | Feb 14, 2022 |
| FY2020 | Dec 31, 2018 | $1.13B | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | ($555.00M) | Feb 14, 2020 |
| FY2016 | Dec 31, 2016 | ($6.00M) | Mar 1, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($535.00M) | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $644.00M | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | $1.66B | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | $773.00M | Feb 11, 2025 |
| FY2023 | Dec 31, 2021 | $2.12B | Feb 13, 2024 |
| FY2022 | Dec 31, 2020 | $1.90B | Feb 13, 2023 |
| FY2021 | Dec 31, 2019 | $434.00M | Feb 14, 2022 |
| FY2020 | Dec 31, 2018 | ($314.00M) | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $804.00M | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | $673.00M | Feb 19, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $101.00M | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $100.00M | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | $84.00M | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | $91.00M | Feb 11, 2025 |
| FY2023 | Dec 31, 2021 | $77.00M | Feb 13, 2024 |
| FY2022 | Dec 31, 2020 | $74.00M | Feb 13, 2023 |
| FY2021 | Dec 31, 2019 | $57.00M | Feb 14, 2022 |
| FY2020 | Dec 31, 2018 | $30.00M | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $86.00M | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | $176.00M | Feb 19, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $15.56B | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $15.63B | Feb 10, 2026 |
| FY2024 | Dec 31, 2023 | $14.89B | Feb 11, 2025 |
| FY2023 | Dec 31, 2022 | $12.31B | Feb 13, 2024 |
| FY2022 | Dec 31, 2021 | $12.21B | Feb 13, 2023 |
| FY2021 | Dec 31, 2020 | $9.53B | Feb 14, 2022 |
| FY2020 | Dec 31, 2019 | $6.79B | Feb 16, 2021 |
| FY2020 | Dec 31, 2018 | $7.15B | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $8.47B | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | $7.45B | Feb 19, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.50B | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $11.13B | Feb 10, 2026 |
| FY2024 | Dec 31, 2023 | $10.68B | Feb 11, 2025 |
| FY2023 | Dec 31, 2022 | $9.35B | Feb 13, 2024 |
| FY2022 | Dec 31, 2021 | $9.58B | Feb 13, 2023 |
| FY2021 | Dec 31, 2020 | $7.44B | Feb 14, 2022 |
| FY2020 | Dec 31, 2019 | $4.83B | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | $5.51B | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | $7.13B | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | $5.80B | Mar 1, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.07B | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $4.50B | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | $4.22B | Feb 10, 2026 |
| FY2025 | Dec 31, 2022 | $2.96B | Feb 10, 2026 |
| FY2024 | Dec 31, 2021 | $2.63B | Feb 11, 2025 |
| FY2023 | Dec 31, 2020 | $2.10B | Feb 13, 2024 |
| FY2022 | Dec 31, 2019 | $1.96B | Feb 13, 2023 |
| FY2021 | Dec 31, 2018 | $1.65B | Feb 14, 2022 |
| FY2020 | Dec 31, 2017 | $1.34B | Feb 16, 2021 |
| FY2019 | Dec 31, 2016 | $1.65B | Feb 14, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.96B | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $1.67B | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | $1.24B | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | $1.12B | Feb 11, 2025 |
| FY2023 | Dec 31, 2021 | $982.00M | Feb 13, 2024 |
| FY2022 | Dec 31, 2020 | $692.00M | Feb 13, 2023 |
| FY2021 | Dec 31, 2019 | $143.00M | Feb 14, 2022 |
| FY2019 | Dec 31, 2018 | $143.00M | Feb 14, 2020 |
| FY2019 | Dec 31, 2017 | $186.00M | Feb 14, 2020 |
| FY2017 | Dec 31, 2016 | $620.00M | Mar 1, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.60B | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $4.09B | Feb 10, 2026 |
| FY2024 | Dec 31, 2023 | $3.89B | Feb 11, 2025 |
| FY2023 | Dec 31, 2022 | $2.80B | Feb 13, 2024 |
| FY2022 | Dec 31, 2021 | $2.40B | Feb 13, 2023 |
| FY2021 | Dec 31, 2020 | $1.86B | Feb 14, 2022 |
| FY2020 | Dec 31, 2019 | $1.78B | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | $1.01B | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | $298.00M | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | $810.00M | Mar 1, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.25B | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $4.66B | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | $4.85B | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | $4.01B | Feb 11, 2025 |
| FY2023 | Dec 31, 2021 | $4.44B | Feb 13, 2024 |
| FY2022 | Dec 31, 2020 | $4.15B | Feb 13, 2023 |
| FY2021 | Dec 31, 2019 | $2.45B | Feb 14, 2022 |
| FY2020 | Dec 31, 2018 | $2.83B | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $3.19B | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | $2.82B | Feb 19, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Dec 31, 2016 | $1.45B | Mar 1, 2017 |
| FY2016 | Dec 31, 2015 | $1.41B | Mar 1, 2017 |
| FY2015 | Dec 31, 2014 | $690.00M | Feb 26, 2016 |
| FY2013 | Dec 31, 2013 | $737.00M | Feb 26, 2014 |
| FY2012 | Dec 31, 2012 | $274.47M | Feb 28, 2013 |
| FY2011 | Dec 31, 2011 | $235.60M | Mar 27, 2012 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 8 | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | 20 | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | 18 | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | 13 | Feb 11, 2025 |
| FY2023 | Dec 31, 2021 | 11 | Feb 13, 2024 |
| FY2022 | Dec 31, 2020 | 11 | Feb 13, 2023 |
| FY2019 | Dec 31, 2019 | 2 | Feb 14, 2020 |
| FY2019 | Sep 30, 2019 | 2 | Feb 14, 2020 |
| FY2019 | Jun 30, 2019 | 3 | Feb 14, 2020 |
| FY2019 | Mar 31, 2019 | 3 | Feb 14, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 8 | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | 20 | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | 18 | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | 13 | Feb 11, 2025 |
| FY2023 | Dec 31, 2021 | 11 | Feb 13, 2024 |
| FY2022 | Dec 31, 2020 | 11 | Feb 13, 2023 |
| FY2019 | Dec 31, 2019 | 2 | Feb 14, 2020 |
| FY2019 | Sep 30, 2019 | 2 | Feb 14, 2020 |
| FY2019 | Jun 30, 2019 | 3 | Feb 14, 2020 |
| FY2019 | Mar 31, 2019 | 2 | Feb 14, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 51.00M | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | 56.00M | Feb 10, 2026 |
| FY2024 | Dec 31, 2023 | 58.00M | Feb 11, 2025 |
| FY2023 | Dec 31, 2022 | 58.00M | Feb 13, 2024 |
| FY2022 | Dec 31, 2021 | 58.00M | Feb 13, 2023 |
| FY2020 | Dec 31, 2020 | 59.00M | Feb 16, 2021 |
| FY2020 | Dec 31, 2019 | 62.00M | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | 62.00M | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | 60.00M | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | 57.00M | Mar 1, 2018 |